Comments on: Oncodesign enters into a research collaboration and license agreement with Sanofi for the application of Oncodesign¹s Nanocyclix(R) technology to Sanofi¹s kinase targets

Comments on: Oncodesign enters into a research collaboration and license agreement with Sanofi for the application of Oncodesign¹s Nanocyclix(R) technology to Sanofi¹s kinase targets https://www.worldpharmatoday.com/press-releases/oncodesign-enters-into-a-research-collaboration-and-license-agreement-with-sanofi-for-the-application-of-oncodesignss-nanocyclixr-technology-to-sanofiss-kinase-targets/ Magazine for the C-level Pharma Executives Wed, 12 Sep 2012 18:30:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4